A novel H2A-A127 variant is associated with human cancer and enhances tumor-related phenotypes in Drosophila melanogaster models - Top-Institutions - MDSpire

A novel H2A-A127 variant is associated with human cancer and enhances tumor-related phenotypes in Drosophila melanogaster models

  • By

  • Zeinab AlHajj Hassan

  • Hassan Dakik

  • Patricia Arreba-Tutusaus

  • Felice Frey

  • Sarah Mantash

  • Amanda Mitchell

  • Meaghan Boileau

  • Sagi Abelson

  • Malak Kleit

  • Zahraa Hayek

  • Jana Awada

  • Roy El Darzi

  • Kolja Eppert

  • Margret Shirinian

  • July 13, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Texas MD Anderson Cancer Center
    University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Cancer Research

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Cancer Research

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology
    • Cancer Research

Original Source(s)

A novel H2A-A127 variant is associated with human cancer and enhances tumor-related phenotypes in Drosophila melanogaster models

  • by Zeinab AlHajj Hassan, Hassan Dakik, Patricia Arreba-Tutusaus, Felice Frey, Sarah Mantash, Amanda Mitchell, Meaghan Boileau, Sagi Abelson, Malak Kleit, Zahraa Hayek, Jana Awada, Roy El Darzi, Kolja Eppert, Margret Shirinian

  • July 13, 2026

Related Content

Navigating the gut–metabolite–immune axis: enhancing efficacy and mitigating toxicity of immune checkpoint inhibitors

A metabolic marker–based diagnostic model for precancerous and malignant endometrial lesions in insulin-resistant PCOS women with sonographically suspected endometrial polyps

Inside the Rise of circRNA

Circio CEO Erik Wiklund reflects on the discovery of human circular RNA and its evolution into a fast-moving therapeutic modality

  • July 9, 2026

  • 12 min